Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:        
Net loss $ (1,765) $ (1,532) $ (5,012) $ (8,433)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization     29
Net loss (gain) on disposal of assets 138 (110)
Stock-based compensation expense     317 806
Change in operating lease right-of-use assets     83 329
Change in finance lease right-of-use assets 4 1 5 3
Gain on the termination of an operating lease (368)
Change in fair value of warrant liability 3,161
Changes in operating assets and liabilities:        
Operating lease liabilities     (532) (558)
Prepaid expenses and other current assets     (105) 524
Accounts payable     459 (15)
Accrued expenses and other liabilities     (36) (1,238)
Net cash used in operating activities     (5,051) (5,502)
Cash flows from investing activities:        
Proceeds from sale of assets     320
Net cash provided by investing activities     320
Cash flows from financing activities:        
Proceeds from the issuance of common stock upon exercise of warrants, net of issuance costs of $337     2,283
Net proceeds from exercise of warrants     64
Payments of finance lease liability – principal     (5) (2)
Net cash provided by financing activities     2,788 3,333
Net decrease in cash, cash equivalents, and restricted cash     (2,263) (1,849)
Cash, cash equivalents, and restricted cash at beginning of period     4,249 7,534
Cash, cash equivalents, and restricted cash at end of period 1,986 5,685 1,986 5,685
Reconciliation of cash, cash equivalents, and restricted cash:        
Cash and cash equivalents 1,936 5,435 1,936 5,435
Restricted cash 50 250 50 250
Total cash, cash equivalents, and restricted cash $ 1,986 $ 5,685 1,986 5,685
Supplemental non-cash financing and investing activities:        
Reclassification of warrants from liability to equity     6,103
Deemed dividend due to Series C Preferred down-round     2,372
Deemed dividend due to 2025 Warrant down-round     1,208
Deemed dividend due to issuance of inducement warrants     3,541
Series D Convertible Preferred Stock [Member]        
Cash flows from financing activities:        
Proceeds from private placement of Series C preferred stock and common stock warrants, net of issue costs of $29     $ 510
Series C Convertible Preferred Stock [Member]        
Cash flows from financing activities:        
Proceeds from private placement of Series C preferred stock and common stock warrants, net of issue costs of $29       $ 3,271